PARATORE, CHIARA
 Distribuzione geografica
Continente #
NA - Nord America 149
EU - Europa 133
AS - Asia 98
AF - Africa 3
SA - Sud America 2
OC - Oceania 1
Totale 386
Nazione #
US - Stati Uniti d'America 136
IT - Italia 56
HK - Hong Kong 21
IE - Irlanda 18
GB - Regno Unito 16
JP - Giappone 16
JO - Giordania 12
CA - Canada 11
SE - Svezia 11
FR - Francia 10
CN - Cina 9
IN - India 8
SG - Singapore 8
PK - Pakistan 7
BE - Belgio 5
ES - Italia 5
FI - Finlandia 4
TR - Turchia 4
EG - Egitto 3
IR - Iran 3
PS - Palestinian Territory 3
CH - Svizzera 2
DE - Germania 2
MX - Messico 2
MY - Malesia 2
PE - Perù 2
TW - Taiwan 2
AM - Armenia 1
AU - Australia 1
GR - Grecia 1
KR - Corea 1
NL - Olanda 1
NO - Norvegia 1
PL - Polonia 1
SA - Arabia Saudita 1
Totale 386
Città #
Chandler 25
Dublin 18
Turin 18
Central 16
New York 16
Amman 12
Nyköping 11
Ashburn 7
Tokyo 7
Karachi 6
Singapore 5
Castellaneta 4
London 4
Manchester 4
Medford 4
Milan 4
Paris 4
Preston 4
Rome 4
Brussels 3
Fairfield 3
Helsinki 3
Hoffman 3
Istanbul 3
Princeton 3
Ramallah 3
River Edge 3
Seattle 3
Torino 3
Wakagi 3
Zibo 3
Bayonne 2
Bhilai 2
Biella 2
Bologna 2
Bury 2
Cergy 2
Cornelius 2
Cuorgnè 2
Florence 2
Giza 2
Hebei 2
Hürth 2
Kanata 2
Kowloon 2
Kuala Lumpur 2
Lima 2
Mexico City 2
Montreal 2
Mount Kisco 2
Mumbai 2
Pamplona 2
Prato 2
Pune 2
San Francisco 2
San Jose 2
Stittsville 2
Taichung 2
Toronto 2
Vancouver 2
Verona 2
Washington 2
Wilmington 2
Zurich 2
Adelaide 1
Amsterdam 1
Ankara 1
Barcelona 1
Bengaluru 1
Bolton 1
Bridgwater 1
Burnaby 1
Cairo 1
Chengdu 1
Como 1
Falls Church 1
Fayetteville 1
Hangzhou 1
Honolulu 1
Hyderabad 1
Krakow 1
Lappeenranta 1
Marseille 1
Melrose 1
Nesttun 1
North Wales 1
Norwalk 1
Otemachi 1
Palermo 1
Piemonte 1
Seoul 1
Strasbourg 1
Tehran 1
Valencia 1
Valladolid 1
Wayne 1
Woodbridge 1
Yerevan 1
Totale 309
Nome #
A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma 181
Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review 122
Local for advanced, is this a paradox? 44
Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer 32
Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020 10
Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study 5
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study 5
Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications 1
Totale 400
Categoria #
all - tutte 1.484
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.484


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202247 3 0 1 0 1 0 5 4 3 3 17 10
2022/2023192 10 20 13 17 20 26 13 16 17 16 17 7
2023/2024161 29 17 13 25 8 21 2 17 8 21 0 0
Totale 400